NOVARTIS PHARMACEUTICALS UK LTD (WT) - WT2024-11, WT2024-12, WT2024-13 - RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections
Value
£1,532,304
Suppliers
Classifications
- Pharmaceutical products
Tags
- award
- contract
Published
7 months ago
Description
Supply of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets to meet clinical need in the Western Trust until 15/08/2027. Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 03/08/2025.
Similar Contracts
Open
London School of Hygiene & Tropical Medicine
Published 7 months ago
Open
Procurement and Logistics Service
Published 1 year ago
AI Bid Assistant
Our AI-powered tool to help you create winning bids is coming soon!
Organisation
Timeline complete
Complete